273,274,275 In AD, cholesterol biosynthesis and catabolism are impaired, contributing to the progression of AD through mediation of A, tau, inflammation, and other pathological changes
Currently, common clinical GLP-1RAs include exenatide and exenatide-LAR [34,35,36,37,38,39,40], lixisenatide [41,42,43,44], beinaglutide [45], liraglutide [46,47,48,49,50,51,52,53], semaglutide [54,55,56,57,58], albiglutide [59,60,61], dulaglutide [62,63,64], oral semaglutide [58, 65,66,67], PEG-loxenatide [68] and tirzepatide [68,69,70,71,72,73] (Table 1)
Customized meal plans, tailored exercise recommendations, and individualized medication regimens contribute to better outcomes
This is especially important for overweight people who often experience carbohydrate metabolism disorders
It must be used as an adjunct to a reduced-calorie diet and increased physical activity
However, if you have documented moderate to severe obstructive sleep apnea alongside obesity, Zepbound may be covered under that indication
